| Literature DB >> 30197954 |
Seyed Ali Tabatabaei1, Mohammad Soleimani1, Mohammad Bagher Rajabi1, Ali Asghar Ahmadraji1, Alireza Khodabandeh1, Amirhoushang Beheshtnejad1, Seyed Mehdi Tabatabaei1, Reza Seidi1, Mehdi Yaseri2.
Abstract
PURPOSE: To report the demographic data, treatment methods, and outcomes among patients with pellet gun eye injuries.Entities:
Keywords: Demographic; Eye; Injury; Outcome; Pellet gun
Year: 2018 PMID: 30197954 PMCID: PMC6127358 DOI: 10.1016/j.joco.2018.01.002
Source DB: PubMed Journal: J Curr Ophthalmol ISSN: 2452-2325
Demographic findings of patients entering the study.
| Parameter | Statistics | Value | |
|---|---|---|---|
| Age | Mean ± SD | 25.7 ± 15.6 | |
| Median (range) | 22 (2–77) | ||
| Age groups | ≤15.0 | 27 (24.3%) | <0.001 |
| 16.0–45.0 | 68 (61.3%) | ||
| 46.0+ | 16 (14.4%) | ||
| Sex | Male | 94 (84.7%) | <0.001 |
| Female | 17 (15.3%) | ||
| Place of residence | Tehran | 18 (16.2%) | <0.001 |
| Cities other than Tehran | 51 (45.9%) | ||
| Rural | 42 (37.8%) | ||
| Time between incident and hospitalization | Same day | 50 (45.0%) | <0.001 |
| After one day | 26 (23.4%) | ||
| After 2 days | 21 (18.9%) | ||
| After 3 days | 8 (7.2%) | ||
| After 4 days | 3 (2.7%) | ||
| After 5 days | 2 (1.8%) | ||
| After 6 days | 0 (0.0%) | ||
| After a week | 1 (0.9%) | ||
| More than a week | 0 (0.0%) | ||
| Intentional or non-intentional | Deliberate injury | 17 (15.3%) | <0.001 |
| Non-deliberate injury | 94 (84.7%) |
SD: Standard deviation.
Test for equality of strata, based on Chi-square test.
Ocular findings before treatment and treatment methods.
| Parameter | Statistics | Values | |
|---|---|---|---|
| Visual acuity | Mean ± SD | 2.56 (CF 10 cm = 20/7260) ± 1.38 | |
| Median (range) | 2.70 (0.15–3.10) | ||
| Ocular Zone | Intact globe | 30 (27.0%) | 0.002 |
| Zone I | 22 (19.8%) | ||
| Zone II | 16 (14.4%) | ||
| Zone III | 43 (38.7%) | ||
| Marcus gun pupil | Negative | 28 (25.2%) | 0.62 |
| +1 | 21 (18.9%) | ||
| +2 | 19 (17.1%) | ||
| +3 | 24 (21.6%) | ||
| +4 | 15 (13.5%) | ||
| Uncooperative | 4 (3.6%) | ||
| Foreign body | No foreign body | 14 (12.6%) | <0.01 |
| Intraocular foreign body | 14 (12.6%) | ||
| Intraorbital foreign body (IOFB) | 83 (74.8%) | ||
| Periocular laceration | No | 84 (75.7%) | <0.001 |
| Yes | 27 (24.3%) | ||
| Ocular Trauma Score (OTS) | 1 | 41 (36.9%) | <0.001 |
| 2 | 39 (35.1%) | ||
| 3 | 11 (9.9%) | ||
| 4 | 4 (3.6%) | ||
| 5 | 16 (14.4%) | ||
| Treatment methods | Only primary repair | 5 (4.5%) | <0.001 |
| Exploration and/or foreign body removal and/or primary repair | 18 (16.2%) | ||
| Lensectomy and/or anterior vitrectomy | 19 (17.1%) | ||
| Pars Plana vitrectomy and/or foreign body removal | 26 (23.4%) | ||
| Lensectomy and/or Pars Plana vitrectomy | 30 (27.0%) | ||
| Enucleation | 20 (18.0%) | ||
| Number of patients in different visual acuity groups | NLP | 36 (32%) | |
| LP-HM | 30 (27%) | ||
| HM < Visual acuity < 1/10 | 37 (33%) | ||
| 1/10 ≤ Visual acuity | 8 (7%) |
SD: Standard deviation, CF: Counting finger, NLP: No light perception, LP: Light perception, HM: Hand motion.
Test for equality of strata, based on Chi-square test.
The change of visual acuity six months after treatment compared to pre-treatment related to baseline findings.
| Parameter | Level | n | Pre | Post | Change | |||
|---|---|---|---|---|---|---|---|---|
| Mean ± SD | Mean ± SD | Mean ± SD | ||||||
| Visual acuity in all patients | 111 | 2.56 (20/7260) ± 1.38 | 2.05 (20/2240) ± 1.5 | −0.51 ± 1.09 | <0.001 | |||
| Ocular Zone | Intact globe | 30 | 1.22 ± 1.32 | 0.028 | 0.96 ± 1.24 | 0.725 | −0.25 ± 0.72 | 0.006 |
| Zone I | 22 | 2.72 ± 1.27 | 2.09 ± 1.44 | −0.64 ± 1.29 | 0.046 | |||
| Zone II | 16 | 2.94 ± 0.35 | 2.46 ± 1.06 | −0.48 ± 0.97 | 0.009 | |||
| Zone III | 43 | 3.06 ± 1.02 | 2.42 ± 1.41 | −0.64 ± 1.23 | 0.001 | |||
| Marcus Gunn Pupil | negative | 28 | 0.6 ± 0.89 | <0.001 | 0.42 ± 0.58 | 0.42 | −0.19 ± 0.66 | 0.02 |
| 1 | 21 | 2.89 ± 0.96 | 2.24 ± 1.33 | −0.65 ± 1.24 | 0.018 | |||
| 2 | 19 | 2.92 ± 0.69 | 2.30 ± 1.31 | −0.62 ± 1.17 | 0.046 | |||
| 3 | 24 | 3.00 ± 0.61 | 2.50 ± 1.34 | −0.50 ± 1.29 | 0.029 | |||
| 4 | 15 | 3.10 ± 0 | 2.79 ± 0.83 | −0.31 ± 0.96 | 0.01 | |||
| Uncooperative | 4 | 3.10 ± 0 | 2.83 ± 1.52 | −0.27 ± 1.52 | 0.041 | |||
| Foreign body | No foreign body | 14 | 1.59 ± 1.49 | 0.005 | 1.39 ± 1.67 | 0.738 | −0.21 ± 0.91 | 0.042 |
| Intraocular foreign body | 14 | 1.45 ± 1.42 | 1.44 ± 1.27 | 0.09 ± 0.01 | 0.181 | |||
| Intraorbital foreign body (IOFB) | 83 | 2.71 ± 1.32 | 2.15 ± 1.45 | −0.55 ± 1.11 | <0.001 | |||
| Lid laceration | No | 84 | 2.73 ± 1.26 | 0.060 | 2.20 ± 1.44 | 0.826 | −0.54 ± 1.08 | 0.001 |
| Yes | 27 | 2.04 ± 1.62 | 1.61 ± 1.61 | −0.43 ± 1.14 | 0.006 | |||
| Ocular Trauma Score (OTS) | 1 | 41 | 2.58 ± 1.39 | 0.225 | 2.06 ± 1.5 | 0.929 | −0.52 ± 1.1 | <0.001 |
| 2 | 39 | 2.36 ± 1.37 | 1.93 ± 1.49 | −0.43 ± 1.05 | 0.276 | |||
| 3 | 11 | 2.56 ± 0.34 | <0.001 | 2.15 ± 1.02 | <0.001 | −0.41 ± 0.95 | 0.003 | |
| 4 | 4 | 2.94 ± 0.57 | 2.05 ± 1.27 | −0.88 ± 1.39 | <0.001 | |||
| 5 | 16 | 1.13 ± 0.7 | 0.52 ± 0.27 | −0.61 ± 0.81 | 0.001 | |||
| Treatment method | Only primary repair | 5 | 0.38 ± 0.26 | 0.26 ± 0.23 | −0.11 ± 0.43 | 0.564 | ||
| Exploration and/or foreign body removal and/or primary repair | 18 | 0.15 ± 0 | 0.26 ± 0.25 | 0.11 ± 0.25 | 0.102 | |||
| Lensectomy and/or anterior vitrectomy | 19 | 2.35 ± 1.73 | <0.001 | 2.00 ± 1.76 | 0.501 | −0.35 ± 0.85 | 0.041 | |
| Pars plana vitrectomy and/or foreign body removal | 26 | 1.05 ± 1.21 | 0.86 ± 1.16 | −0.19 ± 0.66 | 0.038 | |||
| Pars Plana vitrectomy and/or lensectomy | 30 | 3.04 ± 1.073 | 2.06 ± 1.2 | −0.98 ± 1.2 | 0.157 | |||
| Enucleation | 20 | 3.06 ± 0.12 | 3.10 ± 0 | 0.04 ± 0.12 | 0.98 | |||
| Age groups | ≤15.0 | 35 | 2.93 ± 0.81 | 2.08 ± 1.37 | −0.85 ± 1.35 | <0.001 | ||
| 16.0–45.0 | 49 | 3.00 ± 0.65 | 2.52 ± 1.1 | −0.48 ± 0.9 | 0.009 | |||
| 46.0+ | 27 | 2.47 ± 1.51 | 0.449 | 2.10 ± 1.55 | 0.149 | −0.37 ± 0.78 | 0.024 | |
| Endophthalmitis | 4 cases (2.7%) | |||||||
SD: Standard deviation.
Based on Mann-Whitney test.
Based on Kruskal-Wallis test.
Adjusted for the baseline, based on Analysis of Covariance (ANCOVA).
Based on Wilcoxon-Signed rank test.